Stream Bio extends launch of novel bioimaging probes to European markets with CliniSciences and Biotrend

07:03 EDT 24 Oct 2018 | BioNow

Stream Bio Ltd is expanding the distribution network of its transformative Conjugated Polymer Nanoparticle (CPN™) products across Europe. New agreements with life science distributors CliniSciences and Biotrend will make its products available for purchase in France and Germany respectively.Invented in the research labs of King’s College London, Stream Bio’s CPNs™ represent a new generation of novel molecular bioimaging probes. These highly fluorescent, non-toxic nanoparticles are set to revolutionise the bioimaging market with their unique brightness, exceptional stability, magnetic capability and suitability to be conjugated with a range of molecules.  The novel probes have already been launched in the UK and Ireland with 2BScientific.  Distributing with CliniSciences and Biotrend, companies that market high quality products for in vitro research and diagnostics, is a major step forward for Stream Bio and its on-going plan to distribute worldwide. Available for purchase as of today, Stream Bio’s CPNs™ come in four emission wavelengths 475, 510, 550 and 680 nm, covering colours blue, green, yellow and red. Stream Bio’s CPNs™ currently have applications in diagnostics and therapeutics, and have potential to be used in tumour imaging and fluorescence-guided surgery. Stream Bio’s CEO, Andy Chaloner, said: “After the initial launch of our products in the UK and Ireland, we are delighted that our CPNs™ can now also be purchased in Europe. As a start-up biotech company, there is nothing better than seeing your product successfully brought to market. It’s an appreciation of all the hard work and a credit to the entire team at Stream Bio.”  Steve Self, Commercial Director at Stream Bio, said: “We are very excited to launch our CPNs™ with CliniSciences and Biotrend in France and Germany, and look forward to extending this into a number of other EU countries in the near future. We are planning a rapid expansion of the CPN™ range over the coming 12 months, extending their utility into a number of new applications and widening their use in our key areas.”If you would like to work with Stream Bio on development projects and products where CPNs™ could enhance sensitivity or capabilities, please contact: more information, please visit: and follow on Twitter @Stream_Bio.

Original Article: Stream Bio extends launch of novel bioimaging probes to European markets with CliniSciences and Biotrend


More From BioPortfolio on "Stream Bio extends launch of novel bioimaging probes to European markets with CliniSciences and Biotrend"

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...